Pamidronate lines.

dc.contributor.authorSrinivasan, Rameshen_US
dc.date.accessioned2005-09-07en_US
dc.date.accessioned2009-05-27T05:21:27Z
dc.date.available2005-09-07en_US
dc.date.available2009-05-27T05:21:27Z
dc.date.issued2005-09-07en_US
dc.identifier.citationSrinivasan R. Pamidronate lines. Indian Pediatrics. 2005 Sep; 42(9): 959-60en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/10267
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshAntineoplastic Agents --adverse effectsen_US
dc.subject.meshBone Density --drug effectsen_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshDiphosphonates --adverse effectsen_US
dc.subject.meshFemur --drug effectsen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshOsteogenesis Imperfecta --drug therapyen_US
dc.titlePamidronate lines.en_US
dc.typeCase Reportsen_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: